Navigation Links
Group B Strep Screening Guidelines Sparing Newborns

More expectant moms being checked, treated so babies aren't infected, study finds

WEDNESDAY, June 17 (HealthDay News) -- Recommendations implemented in 2002 to screen all pregnant women for group B streptococcal disease have largely been successful, a new report shows.

Eighty-five percent of women in the United States are now being screened and, if positive, given appropriate treatment.

"This paper highlights an important public health success story," said study author Melissa K. Van Dyke, who was an epidemic intelligence service officer at the U.S. Centers for Disease Control and Prevention while conducting the study. "Recommendations for universal antenatal screening were rapidly adopted, and this corresponded with further declines in the incidence of early-onset GBS [group B strep] disease."

Van Dyke is now an epidemiologist at GlaxoSmithKline Biologicals in Rixensart, Belgium, although that company played no part in this study, which appears in the June 18 issue of the New England Journal of Medicine.

"These guidelines have been in place for many years now, and this study was asking whether these guidelines had actually had an impact on care, whether people's behavior had changed," added Dr. James M. Greenberg, director of neonatology at the Cincinnati Children's Hospital Medical Center. "And the answer is yes. Women are getting screened now in much higher percentages, they're getting treated and that has led to a reduction in disease in newborns."

GBS is bacteria that, according to the CDC, became the leading infectious cause of illness and death in newborns in the 1970s. GBS can cause sepsis, meningitis and pneumonia in infants, usually within the first week of life. If a pregnant woman is a carrier, the infection can be passed to her child during delivery.

The guidelines recommend that women get screened at 35 weeks to 37 weeks of pregnancy.

"If a mother is positive for group B strep, she is to get prophylactic antibiotics when she delivers," Greenberg explained. "It requires at least one and preferably two doses of penicillin more than four hours before delivery so it has time to have an effect."

The authors looked at birth records on 254 infants who had GBS disease and 7,437 infants who did not.

Between 1998-1999 and 2003-2004, screening rates jumped from just over 48 percent to 85 percent. This resulted in almost 32 percent of infants being exposed to antibiotics during delivery in the later timeframe, up from about 27 percent in the late 1990s.

Overall, there were 0.32 cases of GBS per 1,000 live births. Infants born premature had a higher incidence of GBS than infants born full-term (0.73 vs. 0.26 cases per 1,000 live births). Yet, most of the cases occurred in full-term infants.

Just over 13 percent of full-term GBS cases occurred in babies of mothers who had not been screened, whereas 61.4 percent occurred in babies of mothers who had actually tested negative for GBS at 35 to 37 weeks of pregnancy.

"Although the antenatal screening strategy has been very successful, we are also exploring ways that we can do even better, and one of them is understanding the issues around false-negatives," Van Dyke said. "While some false-negatives are expected because of the limits of the culture test, we were able to use our study design to show that we observed more false negatives than would be expected."

The term "false-negative" may be a bit of a misnomer, however, Greenberg pointed out.

"If screening is done at 35 weeks gestation, it is possible for a woman who is negative -- i.e., not a carrier -- to become a carrier by the time she delivers," Greenberg said. "Then there's a higher risk that she will pass on group B strep to her infant. Almost all the patients who we see now with group B strep are babies who are born to mothers who had 'false negative' kinds of tests."

One possibility might be to do additional testing later in the pregnancy, Greenberg said. Other instances in which guideline procedures aren't followed involve mothers who come in and deliver too quickly to benefit from antibiotics and women who are allergic to penicillin (although there are other treatment options for these women).

There is also a higher rate of group B strep in black infants than in others, the authors said, but the reasons for this are unclear.

Researchers are still working on a vaccine.

More information

The U.S. Centers for Disease Control and Prevention has more on group B strep.

SOURCES: Melissa K. Van Dyke, Ph.D., epidemiologist, GlaxoSmithKline Biologicals, Rixensart, Belgium; James M. Greenberg, M.D., director, division of neonatology, Cincinnati Children's Hospital Medical Center, Cincinnati; June 18, 2009, New England Journal of Medicine

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. AMERIGROUP Corporation to Present at the 19th Annual Wachovia Mid-Year Equity Conference on June 24
2. Group Health Cooperative Shows Investing in More Primary Care Pays for Itself
3. Group Health Cooperative shows investing in more primary care pays for itself
4. Leading Healthcare Group Selects Varian Medical Systems to Supply Cancer Treatment Technology for Treatment Centers Across the Western United States
5. BurrellesLuce Executive to Speak on Measuring Communications Impact At Joint Seminar of Port-Industry Group and PRSA's Detroit Chapter
6. John Hancock Announces Enhancements to Group Long-Term Care (LTC) Insurance Products and Discount Program
7. A. M. Best Upgrades ProAssurance Group to A (Excellent)
8. Watson to Acquire Arrow Group
9. Linwood Group Research Suggests 3 Questions Everyone Should Ask When Choosing an Alcoholic Residential Centre
10. AGH Joins Select Group of Medical Centers in Study of Promising New Technology for Treatment of Heart Failure
11. Broncus Technologies Exhale Stent and Other New Devices to Prompt Robust Growth In Emphysema Treatment Market, According to Millennium Research Group
Post Your Comments:
Related Image:
Group B Strep Screening Guidelines Sparing Newborns
(Date:11/27/2015)... ... ... According to an article published November 13th on, much ... revolved around the fact that proper dental care, both at-home and in the dental ... periodontal disease (more commonly referred to as gum disease) and diabetes. According to Dr. ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... the way that they are handling security in light of the recent terrorist attacks ... in an attempt to stop an attack from reaching U.S. soil. Especially around special ...
(Date:11/27/2015)... ... ... A team of Swiss doctors has released a report on mesothelioma relapse ... the findings on the website. Click here to read the details now. ... who were treated with chemotherapy followed by EPP surgery. Among the 106 patients who ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When I was ... inventor from Hillside, N.J. "Many people catch diseases simply from sitting on such ... always be protected from germs." , He developed the patent-pending QUDRATECS to eliminate ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... November 27th edition of USA Today in Atlanta, Dallas, New York, Minneapolis, South ... 750,000. The digital component is distributed nationally, through a vast social media strategy ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 2015 ... the  "2016 Future Horizons and Growth ... Monitoring (TDM) Market: Supplier Shares, Country ...  report to their offering.  --> ... addition of the  "2016 Future Horizons ...
(Date:11/26/2015)... , November 26, 2015 ... addition of the "Radioimmunoassay Market by ... (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), ... Global Forecast to 2020" report to ... has announced the addition of the ...
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: AMGN ... Application (BLA) with the United States ... 501, a biosimilar candidate to Humira ® (adalimumab). ... application submitted to the FDA and represents Amgen,s first ... Sean E. Harper , M.D., executive vice president of ...
Breaking Medicine Technology: